ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity
| Autor: | Dalia Žaliūnienė, Ramunė Šepetienė, Albertas Ulys, Vita Lesauskaitė, Milda Juknevičienė, Anželika Slavinska, Kęstutis Sužiedėlis, Daiva Stanislovaitienė, Donatas Stakišaitis |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Blood type Cancer Research medicine.medical_specialty Kidney Bladder cancer business.industry Odds ratio Articles medicine.disease Gastroenterology 03 medical and health sciences Prostate cancer 030104 developmental biology 0302 clinical medicine medicine.anatomical_structure Oncology Prostate 030220 oncology & carcinogenesis ABO blood group system Internal medicine Medicine business Kidney cancer |
| Zdroj: | Oncology letters. 16(1) |
| ISSN: | 1792-1074 |
| Popis: | The aim of the present study was to assess the ABO blood group polymorphism association with prostate, bladder and kidney cancer, and longevity. The following data groups were analyzed: Prostate cancer (n=2,200), bladder cancer (n=1,530), renal cell cancer (n=2,650), oldest-old (n=166) and blood donors (n=994) groups. The data on the ABO blood type frequency and odds ratio in prostate cancer patients revealed a significantly higher blood group B frequency (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|